Federal contract award
75F40124P00500
FURTHER ELUCIDATION OF THE ASSOCIATION BETWEEN THE EXPRESSION OF ?-LACTAMASE ENZYMES AND OTHER PROTEINS AND ANTIMICROBIAL RESISTANCE (AMR) BY STUDYING ADDITIONAL GRAM-NEGATIVE BACTERIAL ISOLATES.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | FDA OFFICE OF ACQ GRANT SVCS |
| NAICS | 541690 — Other Scientific and Technical Consulting Services |
| PSC | AN42 — HEALTH R&D SERVICES; HEALTH CARE - OTHER; APPLIED RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $50.0K |
| Current contract value | $50.0K |
| Potential contract value / ceiling | $154.5K |
| Start date | Sep 23, 2024 |
| Current end date | Mar 13, 2026 |
| Potential end date | Mar 13, 2026 |
| Latest award activity | Aug 27, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 27, 2025 | P00001 | $0 | NO COST MODIFICATION TO CHANGE THE PERIOD OF PERFORMANCE END DATE TO MARCH 13, 2026. |
| Sep 23, 2024 | 0 | $50.0K | FURTHER ELUCIDATION OF THE ASSOCIATION BETWEEN THE EXPRESSION OF ?-LACTAMASE ENZYMES AND OTHER PROTEINS AND ANTIMICROBIAL RESISTANCE (AMR) BY STUDYING ADDITIONAL GRAM-NEGATIVE BACTERIAL ISOLATES. |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.